Disc Medicine Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Disc Medicine Inc's ROI in the third quarter of 2026?
Disc Medicine Inc recorded a cumulative net loss of $-243 million during 12 months ending in the third quarter of 2026, resulting in a negative return on investment (ROI) of -33.72%.

Within the Healthcare sector 394 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 2128 to 3563.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Investment Change TTM	18.36 %	23.39 %	30.36 %	54.9 %	48.07 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	665	705	732	782	612
Return On Investment (TTM)	-33.72 %	-34.75 %	-34.78 %	-30.92 %	-29.73 %
IRON's Overall Ranking	# 3563	# 2128	# 2313	# 3256	#
Seq. Investment Change TTM	1.87 %	1.88 %	1.21 %	12.68 %	6.21 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-243	-246	-242	-212	-181

IRON Company Profile >> Back to IRON Roi Comparisons >> See Annual IRON Return On Investment

Return On Investment IRON's Ranking
Within:	No.
Industry	# 155
Sector	# 395
Overall	# 3563

Return On Investment Statistics
High	Average	Low
-21.86 %	-44.18 %	-150.4 %
(Mar 31 2025)		(Mar 31 2022)

Financial Statements
Disc Medicine Inc's III. Quarter Investments	$ 665 Millions	IRON's Balance sheet
Disc Medicine Inc's III. Quarter Income	$ -60 Millions	Quarterly IRON's Income Statement
IRON's Income by Division		See IRON's Income by Division

IRON Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	770	473	347	178	126
Y / Y Investment Growth	62.68 %	36.62 %	95.1 %	41.42 %	25.89 %
Net Income in Millions	-212	-109	-76	-47	-72
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-27.55 %	-23.1 %	-22.05 %	-26.36 %	-57.22 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
IRON's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for IRON's Competitors
Subscribers only: Roi for Disc Medicine Inc's Suppliers
Subscribers only: Return On Investment for IRON's Customers

Other Ratios
IRON's Roa	IRON's Inventory Turnover Ratio	IRON's Growth Rates	IRON's Dividend Statistics
	IRON's Profitability Ratios	IRON's Asset Turnover Ratio	IRON's Dividend Growth
IRON's Roe	IRON's Valuation Ratios	IRON's Financial Strength Ratios	IRON's Dividend Payout Ratio

Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector

ROI

Date modified: 2026-11-08T19:29:32+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.